AIM
MESO

Acrospire Investment Management’s Mesoblast MESO Stock Holding History

Acrospire Investment Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-350
Closed -$6K – 853
2017
Q2 		$6K Buy
+350
New +$6.56K 0.01% 1930
2016
Q2 		– Sell
-800
Closed -$15K – 2169
2016
Q1 		$15K Buy
+800
New +$11K 0.01% 1631

Other funds holding MESO

PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OWD
Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
DI
Diligent Investors Redlands, California $449M AUM 26.15% 1-Year Est. Return

Acrospire Investment Management's MESO Position: Q3 2017 in Review

Acrospire Investment Management sold out of Mesoblast (MESO) in Q3 2017, closing a stake of 350 shares — an estimated $6K sold.

Acrospire Investment Management first reported a position in MESO in Q1 2016 and held it in 2 quarters. The position peaked at $15K in Q1 2016. 18 funds tracked by Wall St. Rank hold MESO as of Q3 2017.

  • Acrospire Investment Management reported no remaining Mesoblast position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 350 Mesoblast shares in Q3 2017, an estimated $6K.
  • Acrospire Investment Management first reported a position in Mesoblast in Q1 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Mesoblast position peaked at $15K in Q1 2016.
  • 18 funds tracked by Wall St. Rank held Mesoblast as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.